Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABL1 | P00519 | 17/20 | 0.47 |
| ▸ | BCR | P11274 | 17/20 | 0.47 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.45 |
| ▸ | RPS6KB1 | P23443 | 1/20 | 0.45 |
| ▸ | HTR2C | P28335 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3396847 | 0.91 | ABL1 (0.50) | ABL1BCR | |
| SCHEMBL3401720 | 0.82 | SUV39H1 (0.50) | ABL1BCRPDPK1RPS6KB1HTR2C | |
| SCHEMBL3401524 | 0.80 | ABL1 (0.56) | ABL1BCR | |
| SCHEMBL3398709 | 0.78 | ABL1 (0.62) | ABL1BCR | |
| SCHEMBL16331109 | 0.78 | ABL1 (0.62) | ABL1BCR | |
| SCHEMBL3400258 | 0.77 | ABL1 (0.64) | ABL1BCR | |
| SCHEMBL20913066 | 0.77 | ABL1 (0.49) | ABL1BCR | |
| SCHEMBL3399457 | 0.77 | ABL1 (0.49) | ABL1BCR | |
| SCHEMBL3397849 | 0.76 | ABL1 (0.48) | ABL1BCR | |
| SCHEMBL29533373 | 0.76 | ABL1 (0.48) | ABL1BCR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2222162-A2 | SMALL MOLECULE MYRISTATE INHIBITORS OF BCR-ABL AND METHODS OF USE | Dana Farber Cancer Institute (US) | 2010-09-01 | — | — | EP | claimed |
| WO-2009073153-A2 | SMALL MOLECULE MYRISTATE INHIBITORS OF BCR-ABL AND METHODS OF USE | DANA FARBER CANCER INSTITUTE (US) | 2009-06-11 | — | — | WO | claimed |
| EP-2222162-A2 | SMALL MOLECULE MYRISTATE INHIBITORS OF BCR-ABL AND METHODS OF USE | Dana Farber Cancer Institute (US) | 2010-09-01 | — | — | EP | disclosed |
| WO-2009073153-A2 | SMALL MOLECULE MYRISTATE INHIBITORS OF BCR-ABL AND METHODS OF USE | DANA FARBER CANCER INSTITUTE (US) | 2009-06-11 | — | — | WO | disclosed |